SCHEMBL7988558

SCHEMBL7988558

Oc1ccc(-c2nc(O)c3c(ncn3Cc3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MET P08581 3/20 0.43
HPGD P15428 1/20 0.41
ADORA2A P29274 2/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NTSR1 P30989 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA1 P30542 1/20 0.40
HPGDS O60760 1/20 0.39
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
TNF P01375 1/20 0.38
PARN O95453 1/20 0.38
CNOT7 Q9UIV1 1/20 0.38
ESR1 P03372 1/20 0.38
GAA P10253 2/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975267 0.93 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HPGDADORA2AKMT2A
SCHEMBL7984459 0.91 NR1H2 (0.43) SMN1; SMN2ALDH1A1HPGDADORA2AKMT2A
SCHEMBL7975133 0.91 ADORA2A (0.50) SMN1; SMN2ALDH1A1METHPGDADORA2A
Hydrochloric Acid SCHEMBL7985515 0.90 ADORA2A (0.49) SMN1; SMN2ALDH1A1METHPGDADORA2A
SCHEMBL7974507 0.90 MET (0.46) SMN1; SMN2ALDH1A1METHPGDADORA2A
SCHEMBL7988787 0.89 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1METHPGDADORA2A
SCHEMBL7974441 0.89 GRK2 (0.43) SMN1; SMN2ALDH1A1HPGDADORA2AKMT2A
SCHEMBL7974458 0.87 ADORA2A (0.44) SMN1; SMN2ALDH1A1HPGDADORA2AKMT2A
SCHEMBL7985225 0.87 GAA (0.48) SMN1; SMN2ALDH1A1METHPGDADORA3
SCHEMBL7984950 0.86 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1HPGDADORA2AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed